Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s12672-025-02344-2.

Title:
Gene expression profiling and pathway analysis in head and neck squamous cell carcinoma: focus on disulfidptosis | Discover Oncology
Description:
This study aimed to characterize the prognostic and therapeutic implications of disulfidptosis-related genes (DRGs) in head and neck squamous cell carcinoma (HNSCC). Using multi-omics data from the Cancer Genome Atlas (TCGA) (n = 500) and Gene Expression Omnibus (GEO) cohorts (n = 270), we performed unsupervised consensus clustering, functional enrichment, immune deconvolution, and survival analyses to identify DRG-driven molecular subtypes. A disulfidptosis score (DRGscore) was developed via principal component analysis of prognosis-associated genes and validated across immunotherapy cohorts. Key results revealed eight DRGs with prognostic significance (P < 0.05), including RAC1 and SLC7A11, which form interaction networks linked to redox regulation and immune evasion. Four DRGclusters stratified patients into subgroups with distinct survival outcomes (P = 0.002), immune profiles, and pathway activities. DRGscore effectively predicted survival (P < 0.001), immunotherapy response (anti-PD1/PD-L1 cohorts: P = 0.0099–0.018), and drug sensitivity (A443654 IC50 = 0.12 μM vs. AICAR = 8.3 μM). Mutational profiling identified TP53 and MUC16 as high-risk biomarkers. These findings establish DRGscore as a robust prognostic tool integrating disulfidptosis biology and immune contexture, enabling risk-stratified therapeutic strategies for HNSCC.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Science
  • Education
  • Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 8,170,536 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We don’t know how the website earns money.

Websites don't always need to be profitable; some serve as platforms for education or personal expression. Websites can serve multiple purposes. And this might be one of them. Link.springer.com might be making money, but it's not detectable how they're doing it.

Keywords {🔍}

pubmed, article, cell, analysis, immune, google, scholar, genes, fig, cancer, survival, gene, cas, data, prognostic, hnscc, expression, head, neck, carcinoma, subtypes, squamous, correlation, central, disulfidptosis, clusters, disulfidptosisrelated, score, patients, identified, package, drgs, enrichment, drgscore, immunotherapy, clinical, supplementary, full, therapeutic, functional, analyses, molecular, drgclusters, cells, pathways, infiltration, drg, size, material, cohorts,

Topics {✒️}

anti-pd-1/pd-l1 agents anti-pd1/pd-l1 cohorts integrating multi-omics analyses minimal mhc-ii involvement deg-related gene-cluster subtypes article download pdf disulfidptosis-related prognostic model hpv/ebv integration signatures lrpprc-exhibit prognostic relevance potentiating anti-pd-1 efficacy middle-income countries due risk-subtype-survival relationships lrpprc/nckap1-suggest coordinated regulation hpv-related molecular classifications early-stage hepatocellular carcinoma pd-l1-mediated immunosuppression disulfide-centric interaction network platform-specific annotation files disulfidptosis-related gene signatures sex-specific immune modulation disulfidptosis-related lncrna signature mrna stemness indices univariate cox regression rna-based liquid biopsy observed gene–gene interactions yueyang central hospital leveraging immune-active subtypes drg-driven subtypes overlap neck squamous carcinoma univariate regression analysis tumor cell migration interferon-γ/α signaling multi-omics analyses supplementary figures s1-s2 kaplan–meier survival analysis gene expression profiling inter-subtype survival differences immune-related functional activities high/low-risk groups myc-driven metabolic reprogramming high/low-risk cohorts intrinsic/acquired resistance mechanisms exosome rna profiling emphasized epidermal differentiation myeloid-derived suppressor cells harboring advanced-stage patients multi-omics data inputted gene set expression network analysis hnscc tumor-initiating cells

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Gene expression profiling and pathway analysis in head and neck squamous cell carcinoma: focus on disulfidptosis
         description:This study aimed to characterize the prognostic and therapeutic implications of disulfidptosis-related genes (DRGs) in head and neck squamous cell carcinoma (HNSCC). Using multi-omics data from the Cancer Genome Atlas (TCGA) (n = 500) and Gene Expression Omnibus (GEO) cohorts (n = 270), we performed unsupervised consensus clustering, functional enrichment, immune deconvolution, and survival analyses to identify DRG-driven molecular subtypes. A disulfidptosis score (DRGscore) was developed via principal component analysis of prognosis-associated genes and validated across immunotherapy cohorts. Key results revealed eight DRGs with prognostic significance (P < 0.05), including RAC1 and SLC7A11, which form interaction networks linked to redox regulation and immune evasion. Four DRGclusters stratified patients into subgroups with distinct survival outcomes (P = 0.002), immune profiles, and pathway activities. DRGscore effectively predicted survival (P < 0.001), immunotherapy response (anti-PD1/PD-L1 cohorts: P = 0.0099–0.018), and drug sensitivity (A443654 IC50 = 0.12 μM vs. AICAR = 8.3 μM). Mutational profiling identified TP53 and MUC16 as high-risk biomarkers. These findings establish DRGscore as a robust prognostic tool integrating disulfidptosis biology and immune contexture, enabling risk-stratified therapeutic strategies for HNSCC.
         datePublished:2025-04-18T00:00:00Z
         dateModified:2025-04-18T00:00:00Z
         pageStart:1
         pageEnd:18
         license:http://creativecommons.org/licenses/by-nc-nd/4.0/
         sameAs:https://doi.org/10.1007/s12672-025-02344-2
         keywords:
            Head and neck squamous cell carcinoma (HNSCC)
            Disulfidptosis-related genes (DRGs)
            Prognostic model
            Immunotherapy response
            Drug sensitivity
            Oncology
            Cancer Research
            Surgical Oncology
            Molecular Medicine
            Radiotherapy
            Internal Medicine
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12672-025-02344-2/MediaObjects/12672_2025_2344_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12672-025-02344-2/MediaObjects/12672_2025_2344_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12672-025-02344-2/MediaObjects/12672_2025_2344_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12672-025-02344-2/MediaObjects/12672_2025_2344_Fig4_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12672-025-02344-2/MediaObjects/12672_2025_2344_Fig5_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12672-025-02344-2/MediaObjects/12672_2025_2344_Fig6_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12672-025-02344-2/MediaObjects/12672_2025_2344_Fig7_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12672-025-02344-2/MediaObjects/12672_2025_2344_Fig8_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12672-025-02344-2/MediaObjects/12672_2025_2344_Fig9_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12672-025-02344-2/MediaObjects/12672_2025_2344_Fig10_HTML.png
         isPartOf:
            name:Discover Oncology
            issn:
               2730-6011
            volumeNumber:16
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Yajun Tong
               affiliation:
                     name:Yueyang Central Hospital, Hunan Province
                     address:
                        name:Department of Oncology, Yueyang Central Hospital, Hunan Province, Yueyang City, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Site Bai
               affiliation:
                     name:Yueyang Central Hospital, Hunan Province
                     address:
                        name:Department of Oncology, Yueyang Central Hospital, Hunan Province, Yueyang City, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ludi Ou
               affiliation:
                     name:Yueyang Central Hospital, Hunan Province
                     address:
                        name:Department of Oncology, Yueyang Central Hospital, Hunan Province, Yueyang City, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Qiang Zhou
               affiliation:
                     name:Yueyang Central Hospital, Hunan Province
                     address:
                        name:Department of Oncology, Yueyang Central Hospital, Hunan Province, Yueyang City, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Songlian Liu
               affiliation:
                     name:Yueyang Central Hospital, Hunan Province
                     address:
                        name:Department of Oncology, Yueyang Central Hospital, Hunan Province, Yueyang City, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Leilan Yin
               affiliation:
                     name:Yueyang Central Hospital, Hunan Province
                     address:
                        name:Department of Oncology, Yueyang Central Hospital, Hunan Province, Yueyang City, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Kewei Tang
               affiliation:
                     name:Yueyang Central Hospital, Hunan Province
                     address:
                        name:Department of Oncology, Yueyang Central Hospital, Hunan Province, Yueyang City, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ling Long
               affiliation:
                     name:Yueyang Central Hospital, Hunan Province
                     address:
                        name:Department of Oncology, Yueyang Central Hospital, Hunan Province, Yueyang City, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Qinghua Yin
               affiliation:
                     name:Yueyang Central Hospital, Hunan Province
                     address:
                        name:Department of Oncology, Yueyang Central Hospital, Hunan Province, Yueyang City, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Gene expression profiling and pathway analysis in head and neck squamous cell carcinoma: focus on disulfidptosis
      description:This study aimed to characterize the prognostic and therapeutic implications of disulfidptosis-related genes (DRGs) in head and neck squamous cell carcinoma (HNSCC). Using multi-omics data from the Cancer Genome Atlas (TCGA) (n = 500) and Gene Expression Omnibus (GEO) cohorts (n = 270), we performed unsupervised consensus clustering, functional enrichment, immune deconvolution, and survival analyses to identify DRG-driven molecular subtypes. A disulfidptosis score (DRGscore) was developed via principal component analysis of prognosis-associated genes and validated across immunotherapy cohorts. Key results revealed eight DRGs with prognostic significance (P < 0.05), including RAC1 and SLC7A11, which form interaction networks linked to redox regulation and immune evasion. Four DRGclusters stratified patients into subgroups with distinct survival outcomes (P = 0.002), immune profiles, and pathway activities. DRGscore effectively predicted survival (P < 0.001), immunotherapy response (anti-PD1/PD-L1 cohorts: P = 0.0099–0.018), and drug sensitivity (A443654 IC50 = 0.12 μM vs. AICAR = 8.3 μM). Mutational profiling identified TP53 and MUC16 as high-risk biomarkers. These findings establish DRGscore as a robust prognostic tool integrating disulfidptosis biology and immune contexture, enabling risk-stratified therapeutic strategies for HNSCC.
      datePublished:2025-04-18T00:00:00Z
      dateModified:2025-04-18T00:00:00Z
      pageStart:1
      pageEnd:18
      license:http://creativecommons.org/licenses/by-nc-nd/4.0/
      sameAs:https://doi.org/10.1007/s12672-025-02344-2
      keywords:
         Head and neck squamous cell carcinoma (HNSCC)
         Disulfidptosis-related genes (DRGs)
         Prognostic model
         Immunotherapy response
         Drug sensitivity
         Oncology
         Cancer Research
         Surgical Oncology
         Molecular Medicine
         Radiotherapy
         Internal Medicine
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12672-025-02344-2/MediaObjects/12672_2025_2344_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12672-025-02344-2/MediaObjects/12672_2025_2344_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12672-025-02344-2/MediaObjects/12672_2025_2344_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12672-025-02344-2/MediaObjects/12672_2025_2344_Fig4_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12672-025-02344-2/MediaObjects/12672_2025_2344_Fig5_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12672-025-02344-2/MediaObjects/12672_2025_2344_Fig6_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12672-025-02344-2/MediaObjects/12672_2025_2344_Fig7_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12672-025-02344-2/MediaObjects/12672_2025_2344_Fig8_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12672-025-02344-2/MediaObjects/12672_2025_2344_Fig9_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12672-025-02344-2/MediaObjects/12672_2025_2344_Fig10_HTML.png
      isPartOf:
         name:Discover Oncology
         issn:
            2730-6011
         volumeNumber:16
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Yajun Tong
            affiliation:
                  name:Yueyang Central Hospital, Hunan Province
                  address:
                     name:Department of Oncology, Yueyang Central Hospital, Hunan Province, Yueyang City, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Site Bai
            affiliation:
                  name:Yueyang Central Hospital, Hunan Province
                  address:
                     name:Department of Oncology, Yueyang Central Hospital, Hunan Province, Yueyang City, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ludi Ou
            affiliation:
                  name:Yueyang Central Hospital, Hunan Province
                  address:
                     name:Department of Oncology, Yueyang Central Hospital, Hunan Province, Yueyang City, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Qiang Zhou
            affiliation:
                  name:Yueyang Central Hospital, Hunan Province
                  address:
                     name:Department of Oncology, Yueyang Central Hospital, Hunan Province, Yueyang City, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Songlian Liu
            affiliation:
                  name:Yueyang Central Hospital, Hunan Province
                  address:
                     name:Department of Oncology, Yueyang Central Hospital, Hunan Province, Yueyang City, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Leilan Yin
            affiliation:
                  name:Yueyang Central Hospital, Hunan Province
                  address:
                     name:Department of Oncology, Yueyang Central Hospital, Hunan Province, Yueyang City, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Kewei Tang
            affiliation:
                  name:Yueyang Central Hospital, Hunan Province
                  address:
                     name:Department of Oncology, Yueyang Central Hospital, Hunan Province, Yueyang City, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ling Long
            affiliation:
                  name:Yueyang Central Hospital, Hunan Province
                  address:
                     name:Department of Oncology, Yueyang Central Hospital, Hunan Province, Yueyang City, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Qinghua Yin
            affiliation:
                  name:Yueyang Central Hospital, Hunan Province
                  address:
                     name:Department of Oncology, Yueyang Central Hospital, Hunan Province, Yueyang City, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Discover Oncology
      issn:
         2730-6011
      volumeNumber:16
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Yueyang Central Hospital, Hunan Province
      address:
         name:Department of Oncology, Yueyang Central Hospital, Hunan Province, Yueyang City, China
         type:PostalAddress
      name:Yueyang Central Hospital, Hunan Province
      address:
         name:Department of Oncology, Yueyang Central Hospital, Hunan Province, Yueyang City, China
         type:PostalAddress
      name:Yueyang Central Hospital, Hunan Province
      address:
         name:Department of Oncology, Yueyang Central Hospital, Hunan Province, Yueyang City, China
         type:PostalAddress
      name:Yueyang Central Hospital, Hunan Province
      address:
         name:Department of Oncology, Yueyang Central Hospital, Hunan Province, Yueyang City, China
         type:PostalAddress
      name:Yueyang Central Hospital, Hunan Province
      address:
         name:Department of Oncology, Yueyang Central Hospital, Hunan Province, Yueyang City, China
         type:PostalAddress
      name:Yueyang Central Hospital, Hunan Province
      address:
         name:Department of Oncology, Yueyang Central Hospital, Hunan Province, Yueyang City, China
         type:PostalAddress
      name:Yueyang Central Hospital, Hunan Province
      address:
         name:Department of Oncology, Yueyang Central Hospital, Hunan Province, Yueyang City, China
         type:PostalAddress
      name:Yueyang Central Hospital, Hunan Province
      address:
         name:Department of Oncology, Yueyang Central Hospital, Hunan Province, Yueyang City, China
         type:PostalAddress
      name:Yueyang Central Hospital, Hunan Province
      address:
         name:Department of Oncology, Yueyang Central Hospital, Hunan Province, Yueyang City, China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Yajun Tong
      affiliation:
            name:Yueyang Central Hospital, Hunan Province
            address:
               name:Department of Oncology, Yueyang Central Hospital, Hunan Province, Yueyang City, China
               type:PostalAddress
            type:Organization
      name:Site Bai
      affiliation:
            name:Yueyang Central Hospital, Hunan Province
            address:
               name:Department of Oncology, Yueyang Central Hospital, Hunan Province, Yueyang City, China
               type:PostalAddress
            type:Organization
      name:Ludi Ou
      affiliation:
            name:Yueyang Central Hospital, Hunan Province
            address:
               name:Department of Oncology, Yueyang Central Hospital, Hunan Province, Yueyang City, China
               type:PostalAddress
            type:Organization
      name:Qiang Zhou
      affiliation:
            name:Yueyang Central Hospital, Hunan Province
            address:
               name:Department of Oncology, Yueyang Central Hospital, Hunan Province, Yueyang City, China
               type:PostalAddress
            type:Organization
      name:Songlian Liu
      affiliation:
            name:Yueyang Central Hospital, Hunan Province
            address:
               name:Department of Oncology, Yueyang Central Hospital, Hunan Province, Yueyang City, China
               type:PostalAddress
            type:Organization
      name:Leilan Yin
      affiliation:
            name:Yueyang Central Hospital, Hunan Province
            address:
               name:Department of Oncology, Yueyang Central Hospital, Hunan Province, Yueyang City, China
               type:PostalAddress
            type:Organization
      name:Kewei Tang
      affiliation:
            name:Yueyang Central Hospital, Hunan Province
            address:
               name:Department of Oncology, Yueyang Central Hospital, Hunan Province, Yueyang City, China
               type:PostalAddress
            type:Organization
      name:Ling Long
      affiliation:
            name:Yueyang Central Hospital, Hunan Province
            address:
               name:Department of Oncology, Yueyang Central Hospital, Hunan Province, Yueyang City, China
               type:PostalAddress
            type:Organization
      name:Qinghua Yin
      affiliation:
            name:Yueyang Central Hospital, Hunan Province
            address:
               name:Department of Oncology, Yueyang Central Hospital, Hunan Province, Yueyang City, China
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Oncology, Yueyang Central Hospital, Hunan Province, Yueyang City, China
      name:Department of Oncology, Yueyang Central Hospital, Hunan Province, Yueyang City, China
      name:Department of Oncology, Yueyang Central Hospital, Hunan Province, Yueyang City, China
      name:Department of Oncology, Yueyang Central Hospital, Hunan Province, Yueyang City, China
      name:Department of Oncology, Yueyang Central Hospital, Hunan Province, Yueyang City, China
      name:Department of Oncology, Yueyang Central Hospital, Hunan Province, Yueyang City, China
      name:Department of Oncology, Yueyang Central Hospital, Hunan Province, Yueyang City, China
      name:Department of Oncology, Yueyang Central Hospital, Hunan Province, Yueyang City, China
      name:Department of Oncology, Yueyang Central Hospital, Hunan Province, Yueyang City, China

External Links {🔗}(215)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

5.03s.